Vindi Jurinović

4.6k total citations · 1 hit paper
43 papers, 1.5k citations indexed

About

Vindi Jurinović is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Vindi Jurinović has authored 43 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Vindi Jurinović's work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Acute Myeloid Leukemia Research (7 papers). Vindi Jurinović is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Acute Myeloid Leukemia Research (7 papers). Vindi Jurinović collaborates with scholars based in Germany, United States and United Kingdom. Vindi Jurinović's co-authors include Tobias Herold, Michael von Bergwelt‐Baildon, Johannes C. Hellmuth, Tobias Weinberger, Brian J. Lipworth, Matthias Klein, Andreas Herbst, Burkhard Göke, Frank T. Kolligs and Stefan Krebs and has published in prestigious journals such as Blood, Cancer and Scientific Reports.

In The Last Decade

Vindi Jurinović

36 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19

2020 687 citations Tobias Herold, Vindi Jurinović et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vindi Jurinović Germany	13	552	408	397	373	342	43	1.5k
Guangchang Pei China	18	436 0.8×	306 0.8×	261 0.7×	174 0.5×	123 0.4×	35	1.3k
Chenxi Liu China	18	366 0.7×	267 0.7×	199 0.5×	207 0.6×	102 0.3×	94	1.5k
Bhanu Kanth Manne United States	21	551 1.0×	529 1.3×	306 0.8×	215 0.6×	60 0.2×	44	1.8k
Khalil El Karoui France	21	193 0.3×	328 0.8×	134 0.3×	82 0.2×	233 0.7×	58	1.6k
Yaowu Zhu China	18	470 0.9×	292 0.7×	145 0.4×	212 0.6×	42 0.1×	44	1.1k
Laure-Anne Teuwen Belgium	9	532 1.0×	267 0.7×	178 0.4×	341 0.9×	29 0.1×	25	1.1k
Seyyed Mohammad Amin Kashani Iran	6	197 0.4×	214 0.5×	511 1.3×	110 0.3×	52 0.2×	8	1.0k
Zheng Yang China	19	165 0.3×	379 0.9×	204 0.5×	99 0.3×	68 0.2×	81	1.1k
Lei Gao China	26	222 0.4×	770 1.9×	294 0.7×	145 0.4×	81 0.2×	110	1.8k
Sefer Elezkurtaj Germany	16	263 0.5×	282 0.7×	248 0.6×	193 0.5×	33 0.1×	39	1.0k

Countries citing papers authored by Vindi Jurinović

Since Specialization

Citations

This map shows the geographic impact of Vindi Jurinović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vindi Jurinović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vindi Jurinović more than expected).

Fields of papers citing papers by Vindi Jurinović

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vindi Jurinović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vindi Jurinović. The network helps show where Vindi Jurinović may publish in the future.

Co-authorship network of co-authors of Vindi Jurinović

This figure shows the co-authorship network connecting the top 25 collaborators of Vindi Jurinović. A scholar is included among the top collaborators of Vindi Jurinović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vindi Jurinović. Vindi Jurinović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gioia, Dorit Di, Vindi Jurinović, Stefanie Corradini, et al.. (2025). Primary cardiac sarcoma: insights from two decades of multimodal management at LMU Munich. Cardio-Oncology. 11(1). 58–58.

Jurinović, Vindi, Markus Albertsmeier, Hans Roland Dürr, et al.. (2025). First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis. Journal of Cancer Research and Clinical Oncology. 151(4). 150–150.

Gioia, Dorit Di, Vindi Jurinović, Alexander Klein, et al.. (2025). The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcoma. BMC Cancer. 25(1). 671–671.

Gioia, Dorit Di, Vindi Jurinović, Markus Albertsmeier, et al.. (2025). LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatment. BMC Cancer. 25(1). 496–496. 3 indexed citations

Michl, Marlies, Frederick Klauschen, Thomas Kirchner, et al.. (2024). Identification of a gene expression signature associated with brain metastasis in colorectal cancer. Clinical & Translational Oncology. 26(8). 1886–1895. 3 indexed citations

Hentrich, Marcus, Markus Müller, Christoph Wyen, et al.. (2024). Stage‐adapted treatment of HIV‐associated Hodgkin lymphoma: Long‐term results of a prospective, multicenter study. HemaSphere. 8(7). e68–e68. 1 indexed citations

Jurinović, Vindi, Jörg Kumbrink, Thomas Kirchner, et al.. (2024). TGFβ signalling pathway impacts brain metastases profiles in locally advanced colorectal cancer. Clinical & Experimental Metastasis. 41(5). 687–697.

Vick, Binje, Karsten Spiekermann, Maja Rothenberg‐Thurley, et al.. (2022). WT1 and DNMT3A play essential roles in the growth of certain patient AML cells in mice. Blood. 141(8). 955–960. 1 indexed citations

Carlet, Michela, Karin Schmelz, Tobias Herold, et al.. (2022). X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL. EMBO Molecular Medicine. 15(1). e14557–e14557. 5 indexed citations

10.

Hentrich, Marcus, Mark Bower, Gedske Daugaard, et al.. (2021). Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study. Cancer. 128(2). 260–268. 2 indexed citations

11.

Jurinović, Vindi, Elise Pretzsch, Jörg Kumbrink, et al.. (2021). The association of immunosurveillance and distant metastases in colorectal cancer. Journal of Cancer Research and Clinical Oncology. 147(11). 3333–3341. 9 indexed citations

12.

Hentrich, Marcus, et al.. (2020). Improved outcomes in metastatic germ cell cancer: results from a large cohort study. Journal of Cancer Research and Clinical Oncology. 147(2). 533–538. 6 indexed citations

13.

Herold, Tobias, Vindi Jurinović, Brian J. Lipworth, et al.. (2020). Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. Journal of Allergy and Clinical Immunology. 146(1). 128–136.e4. 687 indexed citations breakdown →

14.

Alig, Stefan, Vindi Jurinović, Alessandro Pastore, et al.. (2019). Impact of age on clinical risk scores in follicular lymphoma. Blood Advances. 3(7). 1033–1038. 15 indexed citations

15.

Jurinović, Vindi, et al.. (2018). Priority-Lasso: a simple hierarchical approach to the prediction of clinical outcome using multi-omics data. BMC Bioinformatics. 19(1). 322–322. 45 indexed citations

16.

Jurinović, Vindi, Bernd Metzner, Michael Pfreundschuh, et al.. (2018). Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group. Biology of Blood and Marrow Transplantation. 24(6). 1172–1179. 61 indexed citations

17.

Hornung, Roman, Vindi Jurinović, Aarif M.N. Batcha, et al.. (2018). Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia. Scientific Reports. 8(1). 11293–11293. 10 indexed citations

18.

Neusser, Michaela, Ni na Rogenhofer, Robert Ochsenkühn, et al.. (2015). Increased chromosome 16 disomy rates in human spermatozoa and recurrent spontaneous abortions. Fertility and Sterility. 104(5). 1130–1137.e10. 40 indexed citations

19.

Herold, Tobias, Medhanie Mulaw, Vindi Jurinović, et al.. (2012). High expression ofMZB1predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature. Leukemia & lymphoma. 54(8). 1652–1657. 23 indexed citations

20.

Gröne, Jörn, Dido Lenze, Vindi Jurinović, et al.. (2011). Molecular profiles and clinical outcome of stage UICC II colon cancer patients. International Journal of Colorectal Disease. 26(7). 847–858. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact